HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term follow-up of idiopathic central serous chorioretinopathy without laser.

AbstractPURPOSE:
The purpose of this study was to observe the varied types of manifestations in the fundus of patients with idiopathic central serous chorioretinopathy (ICSC) without laser treatment and also to assess the ultimate visual outcome in such cases in a long-term follow-up ranging from 7 to 23 years.
METHODS:
This study is confined to 5 selected cases of ICSC which fairly represent the different types of late stage manifestations of the disease in the fundus. Case records from our hospital, as well as available records of previous treatment elsewhere were reviewed. A complete ophthalmological examination, routine laboratory investigations and fluorescein fundus angiography (FFA) were repeated in each case on the day of final evaluation.
RESULTS:
Pigmentary disturbances in the macular area resembling to some extent age-related macular degeneration (AMD), extensive retinal pigment epithelial (RPE) atrophy and macular haemorrhage have been observed in the fundus of the reviewed cases.
CONCLUSIONS:
ICSC runs an unpredictable course and there are no definitive clinical clues to predict its ultimate outcome. Recurrence of the condition is a possibility for a considerable period of time.
AuthorsD Bujarborua
JournalActa ophthalmologica Scandinavica (Acta Ophthalmol Scand) Vol. 79 Issue 4 Pg. 417-21 (Aug 2001) ISSN: 1395-3907 [Print] Denmark
PMID11453866 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Choroid Diseases (complications, diagnosis)
  • Diabetes Mellitus, Type 2 (complications)
  • Fluorescein Angiography
  • Follow-Up Studies
  • Fundus Oculi
  • Humans
  • Macula Lutea (pathology)
  • Male
  • Middle Aged
  • Retinal Diseases (complications, diagnosis)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: